Holen Sie sich die Stockscreener-App
62.78
1.32%
0.82
Handel nachbörslich:
62.37
-0.41
-0.65%
Schlusskurs vom Vortag:
$61.96
Offen:
$62.325
24-Stunden-Volumen:
8.93M
Relative Volume:
0.73
Marktkapitalisierung:
$10.55B
Einnahmen:
$803.32M
Nettoeinkommen (Verlust:
$-709.10M
KGV:
-8.0484
EPS:
-7.8003
Netto-Cashflow:
$-212.68M
1W Leistung:
+18.01%
1M Leistung:
+10.02%
6M Leistung:
+8.26%
1J Leistung:
+0.00%
1-Tages-Spanne:
$61.32
$64.59
1-Wochen-Bereich:
$52.62
$65.35
52-Wochen-Spanne:
$22.89
$91.45
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Vergleichen Sie TEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
62.78 | 9.21B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
283.57 | 38.32B | 2.86B | 780.66M | 1.20B | 4.72 |
|
HQY
Healthequity Inc
|
113.06 | 8.79B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
54.57 | 9.70B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.61 | 6.65B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Insider Sell Alert: Jennifer Doudna Sells Shares of Tempus AI In - GuruFocus
Fraud Investigation: Levi & Korsinsky Investigates Tempus AI, Inc. (TEM) on Behalf of Shareholders - ACCESS Newswire
Tempus AI (NASDAQ:TEM) Shares Up 2.9%Time to Buy? - MarketBeat
Decoding Tempus AI's Options Activity: What's the Big Picture? - Nasdaq
Ark Invest prioritizes companies with AI - Traders Union
Tempus AI short report addressed issues mostly known, says TD Cowen - MSN
Beyond LLMs: How Propense.ai & Tempus AI are Shaking up Legacy Industries - Nasdaq
Tempus AI Stock Price Down 3.1%: Why is TEM stock dropping? - Markets.com
Top Medical Stocks To Research – June 2nd - Defense World
Best Artificial Intelligence Stocks To Watch Now – June 2nd - Defense World
Two Sigma Advisers LP Invests $625,000 in Tempus AI, Inc. (NASDAQ:TEM) - Defense World
Green Alpha Advisors LLC Acquires 18,628 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Lost Money on Tempus AI, Inc. (TEM)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
ProShare Advisors LLC Makes New Investment in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
TEM Investor Notice: Levi & Korsinsky Investigates Tempus AI, Inc. for Securities Law Violations - ACCESS Newswire
Tempus AI (NASDAQ:TEM) Stock Price Down 3.1%Here's Why - MarketBeat
Tempus AI (NASDAQ:TEM) Shares Gap DownTime to Sell? - MarketBeat
Tempus AI Unveils New Liquid Biopsy Assay for Early Immunotherapy Response Monitoring in Cancer - MSN
Future of healthcare? Tempus AI (TEM) quietly embeds 1,000+ AI agents in hospitals - Investorsobserver
TEM stock price analysis: Why Tempus AI Stock Up Today? - Markets.com
Why Tempus AI, Inc. (TEM) Skyrocketed On Monday - MSN
James J. Burns & Company LLC Raises Position in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
These 10 Stocks Blew Past Expectations - Insider Monkey
Why Tempus AI Stock Soared 15% Today - MSN
Levi & Korsinsky Investigating Whether Tempus AI, Inc. (TEM) Misled InvestorsSecurities Law Violations Possible - ACCESS Newswire
Tempus AI, Inc. (TEM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Tempus AI recovers 15% as Wall Street downplays Spruce Point allegations - Investing.com Australia
Tempus AI Expands Tempus One with EHR Integration, New AI Features - Insider Monkey
Tempus AI Sees Unusually Large Options Volume (NASDAQ:TEM) - MarketBeat
Tempus AI recovers after TD Cowen criticizes short report - Seeking Alpha
Tempus AI (NASDAQ:TEM) Stock Price Up 13.9%Still a Buy? - MarketBeat
Tempus AI, Inc. (TEM) Launches ‘Fuses’ to Power AI-Driven Precision Diagnostics - MSN
Tempus AI rebound, Meta's AI ad push, Broadcom earnings optimism - Yahoo Finance
TD Cowen maintains buy rating on Tempus AI stock after short report - Investing.com Nigeria
Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeHere's Why - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc.TEM - FinancialContent
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are ... - Eagle-Tribune
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - TradingView
Tempus AI Stock Rockets After Introduction Of Liquid Biopsy Assay For Cancer Treatment Monitoring: Retail Hopes For A 20% Rally - Asianet Newsable
Tempus AI jumps after hit from short seller’s report - Sherwood News
tempus AI Inc Class A call volume above normal and directionally bullish - TipRanks
Tempus AI, Inc. Class A Stocks Surge Amid Market Buzz - TipRanks
Tempus AI (TEM) Stock Skyrockets Over 13% on Strong Investor Demand - Daily Chhattisgarh News
Tempus AI (TEM) Stock Surges Over 13% on Nasdaq, Trades Above $62 - Daily Chhattisgarh News
Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Lost Investment in Tempus AI, Inc. (TEM)? Levi & Korsinsky Launches Securities Fraud Investigation - ACCESS Newswire
Tempus AI unveils liquid biopsy for cancer treatment monitoring By Investing.com - Investing.com Canada
Tempus AI unveils liquid biopsy for cancer treatment monitoring - Investing.com
Tempus Introduces xM, An Assay To Monitor Immunotherapy Response For Patients With Advanced Cancers - marketscreener.com
Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers - Eagle-Tribune
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.96%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):